Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | SS Innovations International, Inc. - 10-Q/A, Quarterly Report | - | SEC Filings | ||
Mo | SS Innovations International, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
Mo | SS Innovations Achieves Significant Milestones in 2024 | 148 | GlobeNewswire (Europe) | The Company's award winning SSi Mantra surgical robotic system has completed over 3,500 surgeries and is clinically validated to perform more than 100 different types of surgical procedures The Company... ► Artikel lesen | |
Fr | SS Innovations secures regulatory approvals for surgical robotic system in the Philippines, Ukraine | 1 | Seeking Alpha | ||
Fr | SS Innovations unveils mobile tele-surgical unit | 3 | MassDevice | ||
SS INNOVATIONS INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
Fr | SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine | 146 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) ("SS Innovations" or the "Company"), a developer of innovative surgical robotic technologies... ► Artikel lesen | |
27.03. | SS Innovations International, Inc. - 8-K, Current Report | - | SEC Filings | ||
27.03. | SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System | 3 | GlobeNewswire (USA) | ||
13.03. | SS Innovations Unveils India's First Mobile Tele-Surgical Unit at SMRSC 2025 | 1 | GlobeNewswire (USA) | ||
10.03. | SS Innovations International, Inc. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
07.03. | SS Innovations International, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
19.02. | SS Innovations International, Inc. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
24.01. | SS Innovations International, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
14.01. | SS Innovations International, Inc. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
13.01. | SS Innovations reports first robotic cardiac telesurgeries | 2 | MassDevice | ||
13.01. | SS Innovations International, Inc. - 8-K, Current Report | - | SEC Filings | ||
20.12.24 | SS Innovations International, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
11.12.24 | SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting | 98 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Dec. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC: SSII), developer of innovative surgical robotic technologies dedicated... ► Artikel lesen | |
10.12.24 | SS Innovations: India's First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way | 3 | GlobeNewswire (USA) | ||
10.12.24 | SS Innovations International, Inc. - 8-K, Current Report | - | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 39,500 | +0,05 % | Fresenius SE: Fresenius Medical Care von 32,2 % auf 25 Prozent zu verringern | Aktie im Fokus, die Aktuelle Analyse am 27.03.2025 | ||
SIEMENS HEALTHINEERS | 50,10 | -0,04 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum zweiten Quartal auf "Buy" mit einem Kursziel von 65 Euro belassen. Die Geschäfte in... ► Artikel lesen | |
CARL ZEISS MEDITEC | 55,55 | -5,45 % | Dividendenbekanntmachungen (27.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC GB00BF8Q6K64 0,073 GBP 0,0875 EUR AFRICA OIL CORP CA00829Q1019 0,0371 USD 0,0345 EUR AGL ENERGY LIMITED AU000000AGL7 0... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 18,180 | 0,00 % | BrightSpring Health Services (BTSG): Among Top High-Risk, High-Reward Growth Stocks To Buy Now | ||
FRESENIUS MEDICAL CARE | 45,570 | -0,68 % | AKTIEN IM FOKUS: Aktien aus Gesundheitsbranche leiden stark unter Zollangst | FRANKFURT (dpa-AFX) - Aus Sorge vor Donald Trumps Zollpolitik haben die Anleger am Mittwoch branchenweit bei Gesundheitswerten den Rückzug angetreten. Im Dax erwischte es Bayer am stärksten mit einem... ► Artikel lesen | |
GERRESHEIMER | 67,90 | -1,16 % | Aurubis, Evonik, Gerresheimer, Nagarro, SMA Solar, TUI u.a. - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
GOODRX | 4,570 | 0,00 % | GoodRx Reports Third Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 6,630 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2024 Results | SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
UNITEDHEALTH | 482,60 | +0,10 % | UnitedHealth Group, PG&E And A Financial Stock On CNBC's 'Final Trades' | ||
BETA BIONICS | 12,050 | +7,21 % | Q1 EPS Estimates for Beta Bionics Reduced by Leerink Partnrs | ||
ECKERT & ZIEGLER | 54,95 | -1,08 % | Eckert & Ziegler will weiter zulegen - Cyberattacke verzögert Geschäftsbericht | BERLIN (dpa-AFX) - Der Strahlen- und Medizintechnikkonzern Eckert & Ziegler erwartet im neuen Jahr weiteres Wachstum. Der Umsatz soll um etwa acht Prozent auf rund 320 Millionen Euro zulegen, wie das... ► Artikel lesen | |
DRAEGERWERK | 67,40 | -1,61 % | Drägerwerk: Hauck Aufhäuser Lampe sieht rund 30 Prozent Gewinnpotenzial! | ||
ALIGNMENT HEALTHCARE | 17,845 | 0,00 % | Alignment Healthcare-CIO Robert Scavo verkauft Aktien im Wert von 51.236 US-Dollar | ||
GENEDX | 84,76 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
INTUITIVE SURGICAL | 467,90 | +0,07 % | National Wealth Management Group LLC Takes $436,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG) |